Clinical Trial Update: A 6-month Study to Evaluate Sulforaphane add-on Effects in Treatment of Schizophrenia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating sulforaphane as an add-on therapy for schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Sulforaphane (sulforaphane)

Snippet

Sponsor: Central South University | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED